当前位置:首页 - 行情中心 - 九洲药业(603456) - 财务分析

九洲药业

(603456)

  

流通市值:114.20亿  总市值:114.20亿
流通股本:8.89亿   总股本:8.89亿

九洲药业(603456)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润1.68亿元,每股收益0.19元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益895315.93万元,未分配利润348851.40万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产1058843.10万元,负债163527.17万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入1,200,661,700.095,508,595,171.334,160,487,725.652,870,947,333.22
营业总成本977,467,580.384,293,596,413.643,195,334,808.192,196,824,757.62
其他经营收益
营业利润219,838,486.07924,945,257.44912,351,045.88653,590,597.69
利润总额219,857,867.46919,451,398.52909,807,395.65650,314,797.16
净利润168,270,923.2728,543,117.48748,674,344.04526,613,903.71
每股收益
其他综合收益-8,776,591.02-1,972,075.013,761,640.597,280,131.47
综合收益总额159,494,332.18726,571,042.47752,435,984.63533,894,035.18
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计5,364,104,245.955,537,378,379.795,518,729,793.695,814,592,964.26
非流动资产:
非流动资产合计5,224,326,737.835,065,608,803.925,200,007,694.165,140,507,903.47
资产总计10,588,430,983.7810,602,987,183.7110,718,737,487.8510,955,100,867.73
流动负债:
流动负债合计1,401,203,792.381,577,607,478.051,626,561,569.921,904,995,740.18
非流动负债:
非流动负债合计234,067,928.55234,781,383.17267,966,711.58270,842,005.4
负债合计1,635,271,720.931,812,388,861.221,894,528,281.52,175,837,745.58
所有者权益(或股东权益):
归属于母公司股东权益合计8,890,493,786.658,724,119,572.528,755,178,673.488,710,471,563.76
股东权益合计8,953,159,262.858,790,598,322.498,824,209,206.358,779,263,122.15
负债和股东权益合计10,588,430,983.7810,602,987,183.7110,718,737,487.8510,955,100,867.73
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计1,351,032,016.995,849,553,071.594,725,571,418.113,119,108,184.61
经营活动现金流出小计1,215,085,027.514,025,306,849.663,383,566,378.622,273,960,040
经营活动产生的现金流量净额135,946,989.481,824,246,221.931,342,005,039.49845,148,144.61
投资活动产生的现金流量:
投资活动现金流入小计344,992,664.5710,360,577.085,822,915.534,749,630.81
投资活动现金流出小计487,399,226.622,042,460,578.66534,459,528.27387,285,184.8
投资活动产生的现金流量净额-142,406,562.05-2,032,100,001.58-528,636,612.74-382,535,553.99
筹资活动产生的现金流量:
筹资活动现金流入小计90,000,000470,000,000470,000,000300,000,000
筹资活动现金流出小计51,230,0301,382,712,697.91,305,569,005.33673,808,894.79
筹资活动产生的现金流量净额38,769,970-912,712,697.9-835,569,005.33-373,808,894.79
汇率变动对现金及现金等价物的影响-18,500,052.73-17,015,588.67-4,113,3554,568,061.65
现金及现金等价物净增加额13,810,344.7-1,137,582,066.22-26,313,933.5793,371,757.49
期末现金及现金等价物余额1,469,910,273.441,456,099,928.742,567,368,061.392,687,053,752.45
补充资料:
现金及现金等价物的净增加额--1,137,582,066.22-93,371,757.49
最新报告期:2026-05-08
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
长城国瑞证券胡晨曦,魏钰琪0.850.920.972026-05-08
中信建投王云鹏,袁清慧0.911.061.242026-05-06
中信建投王云鹏,袁清慧0.911.061.242026-05-05
华泰证券代雯,袁中平,陈睿恬0.961.021.072026-04-24
中金公司俞波,张琎,吴婉桦0.961.02--2026-04-24
TOP↑